Stocktoria
AGIOS PHARMACEUTICALS, INC. AGIO
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2013-07-24
AGIOS PHARMACEUTICALS, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -873.9% | -1166.5% | -1459.5% | -2732.1% | — |
| Net margin | -764.0% | 1845.9% | -1312.6% | -1627.8% | — |
| FCF margin | -698.3% | -1072.7% | -1107.5% | -2207.6% | — |
| Return on assets | -31.8% | 40.5% | -37.6% | -18.7% | 111.6% |
| Return on equity | -34.6% | 43.7% | -43.4% | -21.1% | 124.2% |
| Current ratio | 11.46 | 11.90 | 12.27 | 13.30 | 17.79 |
| Revenue growth | 48.0% | 36.1% | 88.4% | — | — |
Source: SEC EDGAR filings · CIK 0001439222 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.